EUVIMEDEUVIMED entdecken
Crossref

EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC

Yue Yu, Hesham MohamedAl-Sharani, Bin Zhang iD

Oral Diseases · 2023-04 · 29 (3) · 880-891

DOI: 10.1111/odi.14040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 15.11.2021. Verfasst von Yue Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oral and Maxillofacial Surgery Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Squamous Cell, Ferroptosis, Esophageal Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Tongue squamous cell carcinoma is one of the most common carcinomas in oral cancer with a high morbidity and mortality. Ferroptosis is a novel type of cell death involved in various diseases including cancers. Additionally, Enhancer of Zeste homolog 2 (EZH2) is significantly associated with a poor prognosis in esophageal squamous cell carcinoma patients but its role in TSCC is unclear. Materials and Methods In this study, we tried to investigate the possible mechanism of EZH2 involved in the ferroptosis of TSCC. Expression of EZH2 and SLC7A11 was determined by RT‐qPCR. CCK‐8 assays were performed to quantify the cell death rate of TSCC cells. Malondialdehyde (MDA) assays were performed to quantify the lipid accumulation. Western blot was performed to analyze the expression level of SLC7A11. We used dual‐luciferase reporter assays to determine the association between EZH2 and miR‐125b‐5p promoter, and miR‐125b‐5p and the SLC7A11 3’ untranslated region (UTR).

Result

Overexpression of EZH2 and SLC7A11 inhibits erastin‐induced ferroptosis in TSCC cells. MiR‐125b‐5p regulates ferroptosis in TSCC cells by targeting SLC7A11. EZH2 inhibits the ferroptosis of TSCC cells by inhibiting miR‐125b‐5p and enhancing SLC7A11.

Conclusion

EZH2 inhibits erastin‐induced ferroptosis in TSCC cells via miR‐125b‐5p/SLC7A11 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, Squamous CellFerroptosisEsophageal NeoplasmsTongue NeoplasmsEsophageal Squamous Cell CarcinomaHumansUp-RegulationEnhancer of Zeste Homolog 2 ProteinCell ProliferationCell Line, TumorAmino Acid Transport System y+

Stichwörter der Autor:innen

EZH2SLC7A11ferroptosismiR-125b-5ptongue squamous cell carcinoma

Substanzen

MicroRNAsEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanSLC7A11 protein, humanAmino Acid Transport System y+

Autor:innen und Institutionen

  • Oral and Maxillofacial Surgery Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Department of Oral and Maxillofacial Surgery, College of Dentistry, Ibb University, Ibb, Yemen.

ORCID-Profile: Bin Zhang

Zitieren

APA

Yu, Y., MohamedAl-Sharani, H., & Zhang, B. (2023). EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC. Oral Diseases, 29(3), 880-891. https://doi.org/10.1111/odi.14040

Vancouver

Yu Y, MohamedAl-Sharani H, Zhang B. EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC. Oral Diseases. 2023;29(3):880-891. doi:10.1111/odi.14040

BibTeX
@article{Yu2023,
  author = {Yu, Yue and MohamedAl-Sharani, Hesham and Zhang, Bin},
  title = {EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC},
  journal = {Oral Diseases},
  year = {2023},
  volume = {29},
  number = {3},
  pages = {880--891},
  doi = {10.1111/odi.14040}
}
Kostenlos starten →